Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Thursday, September 26, 2013

Cerulean Pharma Inc. Release: Combinability of CRLX101 and...

Patients treated with CRLX101 and AvastinA at their respective MTDs did not require treatment discontinuations or dose reductions.

http://www.biospace.com/news_story.aspx?StoryID=309939&full=1
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Stem Cell Roundup Posts